![]() |
市場調査レポート
商品コード
1541354
眼内レンズ市場レポート:製品、材料、最終用途、地域別、2024~2032年Intraocular Lens Market Report by Product, Material (Polymethylmethacrylate, Silicone, Hydrophobic Acrylic), End Use, and Region 2024-2032 |
||||||
カスタマイズ可能
|
眼内レンズ市場レポート:製品、材料、最終用途、地域別、2024~2032年 |
出版日: 2024年08月10日
発行: IMARC
ページ情報: 英文 139 Pages
納期: 2~3営業日
|
世界の眼内レンズ(IOL)市場規模は2023年に42億米ドルに達しました。今後、IMARC Groupは、2024~2032年にかけて4.5%の成長率(CAGR)を示し、2032年には63億米ドルに達すると予測しています。同市場は、白内障罹患率の上昇を伴う高齢化人口の増加、眼内レンズの設計を強化する継続的な技術革新、眼科医療に対する世界の意識とアクセシビリティの向上などに牽引され、着実な成長を遂げています。
市場の成長と規模:高齢化と白内障手術の増加により、世界市場は力強い成長を遂げています。加齢に伴う眼疾患の世界の流行により、製品需要は着実に増加しており、市場規模は相当なものです。
主要市場促進要因:特に北米、欧州、アジア太平洋における世界の高齢化人口の増加が、眼内レンズの需要に大きく貢献しています。目の健康に対する意識の高まり、医療サービスの利用しやすさ、手術技術の進歩は市場成長を促進する主要要因です。
技術の進歩:現在進行中の技術革新は、高度疎水性アクリルなどのレンズ材料や、多焦点レンズ、トーリックレンズなどのデザインの改良に重点を置いています。精密製造技術の統合は、これらのレンズのカスタマイズ性と有効性を高め、患者に視覚的転帰の改善を記載しています。
産業用途:これらのレンズは白内障手術、加齢に伴う視力問題や屈折異常への対応に幅広く使用されています。多焦点眼内レンズの多用途性は患者の幅広いニーズに対応し、近方視力と遠方視力の両方で眼鏡への依存を軽減します。
主要市場動向:市場動向には、視力の向上と矯正眼鏡への依存度の低減に対する嗜好の高まりを反映した、多焦点眼内レンズとプレミアム眼内レンズへのシフトが含まれます。主要企業間の提携、買収、パートナーシップは、製品ポートフォリオと世界市場でのプレゼンス強化のための戦略的イニシアチブの傾向を特徴付ける。
地理的動向:北米は、先進的な医療インフラ、償還政策、加齢に伴う眼疾患の高い発生率に牽引され、市場を独占しています。アジア太平洋は、人口の多さ、意識の高まり、医療サービスへのアクセスの増加により、著しい成長を遂げています。
競合情勢:市場の主要参入企業は研究開発に積極的に取り組んでおり、製品のイノベーション、戦略的提携、地理的拡大に注力しています。競合情勢の特徴として、主要企業は競争優位性を維持するために疎水性アクリルなどの先端技術に投資しています。
課題と機会:課題としては、費用対効果の高いソリューションの必要性や、特定の材料に伴う合併症への対応が挙げられます。ビジネス機会は、新興市場の未開拓の可能性、技術の進歩、高級眼内レンズに対する需要の高まりへの対応にあります。
将来の展望世界人口の高齢化と技術の絶え間ない進歩に牽引され、持続的な成長が見込まれる世界市場の将来展望は有望です。市場拡大の機会は、進化する患者ニーズへの対応、新興市場への注力、革新的な材料や設計を活用した手術成績の向上から生まれると考えられます。
高齢者人口の増加と白内障罹患率
世界の高齢化の進展は、眼内レンズ市場を推進する重要な要因です。高齢化に伴い、白内障を発症するリスクが高まり、視力回復のための外科的介入が必要となります。一般的な加齢に伴う眼疾患である白内障は、眼の天然レンズを曇らせ、視力障害につながります。人口の高齢化に伴い、白内障の有病率が上昇し、眼内レンズ移植術の需要が高まっています。世界保健機関(WHO)は、60歳以上の世界人口のかなりの部分が白内障に罹患していると推定しており、主要な治療オプションとしての眼内レンズの必要性を高めています。手術技術や眼内レンズ設計の進歩も市場成長に寄与しており、白内障患者により安全で効果的なソリューションを提供しています。
技術革新と製品の進歩
レンズ設計と材料における継続的な技術進歩とイノベーションは、市場拡大の極めて重要な要因です。眼科業界の主要参入企業による継続的な研究開発の努力は、多焦点性、焦点深度の拡大、生体適合性の向上などの機能を強化した先進的な眼内レンズの採用つながっています。疎水性アクリルや親水性アクリルのような最先端材料の統合は、光学的結果を改善し、術後合併症のリスクを低減します。さらに、精密製造技術の出現は眼内レンズのカスタマイズに貢献し、患者の多様なニーズに応えています。外科医は、より良い視力と矯正眼鏡への依存度の低減を可能にする技術的に進歩した眼内レンズをますます好むようになっており、それによって市場の成長が促進されています。
眼科医療に対する世界の認識とアクセシビリティの向上
目の健康の重要性に対する意識の高まりと、先進的な眼科治療の利用可能性は、市場の拡大に大きく貢献しています。政府、非営利団体、医療プロバイダーによる白内障、屈折異常、時宜を得た外科的介入の利点に関する意識向上への取り組みは、患者教育を推進しています。さらに、特に発展途上地域では眼科医療サービスへのアクセスが向上し、眼疾患の早期診断と治療が容易になっています。意識が高まるにつれて、医療介入を求める傾向が強まり、眼内レンズ移植術の需要を促進しています。世界の意識向上への取り組みと医療インフラの改善が組み合わさることで、より多くの人口が眼内レンズ移植にアクセスし、その恩恵を受けられるようになり、市場の成長が維持されます。
The global intraocular lens market size reached US$ 4.2 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 6.3 Billion by 2032, exhibiting a growth rate (CAGR) of 4.5% during 2024-2032. The market is experiencing steady growth driven by a growing aging population with increased cataract incidence, continual technological innovations enhancing IOL designs, and rising global awareness and accessibility to eye care, collectively fostering demand for advanced surgical interventions and propelling market expansion.
Market Growth and Size: The global market is experiencing robust growth, driven by an aging population and an increase in cataract surgeries. The market size is substantial, with a steady rise in the product demand due to the prevalence of age-related eye conditions worldwide.
Major Market Drivers: Growing aging populations globally, especially in North America, Europe, and Asia Pacific, contribute significantly to the demand for intraocular lenses. Increasing awareness of eye health, accessibility to healthcare services, and advancements in surgical techniques are key drivers propelling market growth.
Technological Advancements: Ongoing technological innovations focus on improving lens materials, such as advanced hydrophobic acrylics, and designs, including multifocal and toric lenses. The integration of precision manufacturing technologies enhances the customization and effectiveness of these lenses, offering patients improved visual outcomes.
Industry Applications: These lenses find extensive applications in cataract surgeries, addressing age-related vision issues and refractive errors. The versatility of multifocal intraocular lenses caters to a broad range of patient needs, reducing dependence on glasses for both near and far vision.
Key Market Trends: The market trends include a shift towards multifocal and premium IOLs, reflecting a growing preference for enhanced visual acuity and reduced dependence on corrective eyewear. Collaborations, acquisitions, and partnerships among key players characterize the trend of strategic initiatives to strengthen product portfolios and global market presence.
Geographical Trends: North America dominates the market, driven by advanced healthcare infrastructure, reimbursement policies, and a high incidence of age-related eye conditions. The Asia Pacific region is witnessing significant growth due to a large population, rising awareness, and increasing access to healthcare services.
Competitive Landscape: Key players in the market are actively engaged in research and development, focusing on product innovation, strategic collaborations, and geographic expansion. The competitive landscape is characterized by major players investing in advanced technologies, such as hydrophobic acrylics, to maintain a competitive edge.
Challenges and Opportunities: Challenges include the need for cost-effective solutions and addressing complications associated with certain materials. Opportunities lie in the untapped potential of emerging markets, technological advancements, and meeting the rising demand for premium intraocular lenses.
Future Outlook: The future outlook for the global market is promising with sustained growth anticipated, driven by an aging global population and continual advancements in technology. Opportunities for market expansion will arise from addressing evolving patient needs, focusing on emerging markets, and leveraging innovative materials and designs to enhance surgical outcomes.
Growing geriatric population and cataract incidence
The escalating global aging population is a significant driver propelling the IOL market. As individuals age, the risk of developing cataracts increases, necessitating surgical intervention for vision restoration. Cataracts, a common age-related ocular condition, cloud the eye's natural lens, leading to impaired vision. With the aging demographic, there is a rise in the prevalence of cataracts, fostering the demand for IOL implantation procedures. The World Health Organization estimates that a substantial portion of the global population over 60 years old is affected by cataracts, driving the need for IOLs as a primary treatment option. Advancements in surgical techniques and IOL designs also contribute to market growth, providing safer and more effective solutions for cataract patients.
Technological innovations and product advancements
Ongoing technological advancements and innovations in the lens design and materials are pivotal factors fueling market expansion. Continuous research and development efforts by key players in the ophthalmic industry result in the introduction of advanced IOLs with enhanced features, such as multifocality, extended depth of focus, and improved biocompatibility. The integration of cutting-edge materials, like hydrophobic and hydrophilic acrylics, offers improved optical outcomes and reduces the risk of postoperative complications. Additionally, the advent of precision manufacturing technologies contributes to the customization of IOLs, catering to diverse patient needs. Surgeons increasingly prefer technologically advanced IOLs that enable better visual acuity and reduced dependence on corrective eyewear, thereby driving the growth of the market.
Rising global awareness and accessibility to eye care
Increasing awareness about the importance of eye health and the availability of advanced ophthalmic treatments contribute significantly to the expansion of the market. Efforts by governments, non-profit organizations, and healthcare providers to raise awareness about cataracts, refractive errors, and the benefits of timely surgical interventions propel patient education. Moreover, improved accessibility to eye care services, especially in developing regions, facilitates early diagnosis and treatment of ocular conditions. As awareness grows, individuals are more likely to seek medical intervention, driving the demand for intraocular lens implantation procedures. The combination of awareness initiatives and improved healthcare infrastructure globally ensures that a larger proportion of the population can access and benefit from IOL implants, sustaining market growth.
IMARC Group provides an analysis of the key trends in each segment of the market, along with forecasts at the global, regional, and country levels for 2024-2032. Our report has categorized the market based on product, material and end use.
Monofocal IOL
Multifocal IOL
Toric IOL
Accommodative IOL
Multifocal IOL account for the majority of the market share
The report has provided a detailed breakup and analysis of the market based on the product. This includes monofocal IOL, multifocal IOL, toric IOL, and accommodative IOL. According to the report, multifocal IOL represented the largest segment.
Multifocal IOLs dominate the market as the largest segment, offering a comprehensive solution to age-related vision issues. These lenses provide multiple focal points, allowing patients to achieve clear vision at various distances, reducing dependence on glasses after cataract surgery. With an aging population seeking enhanced visual acuity for both near and far distances, multifocal IOLs have gained prominence. The versatility they offer aligns with the lifestyle demands of individuals desiring improved vision across different activities, from reading to driving, making them a preferred choice in the market.
Monofocal IOLs represent a significant segment of the market, serving as a traditional and cost-effective option for cataract surgery. These lenses have a single focal point, typically set for distance vision, necessitating the use of glasses for activities requiring near vision. While lacking multifocal versatility, monofocal IOLs remain popular due to their reliability and affordability, catering to patients with specific visual needs and budget constraints.
Toric IOLs address astigmatism, a common refractive error, making them a crucial segment in the market. These lenses correct both cataracts and astigmatism simultaneously, enhancing visual outcomes for patients with irregular corneal shapes. With an increasing prevalence of astigmatism globally, toric IOLs have witnessed growing demand, offering patients the opportunity to achieve better visual clarity without additional surgical interventions or reliance on corrective eyewear.
Accommodative IOLs represent an innovative segment designed to mimic the eye's natural ability to adjust focus. These lenses provide a dynamic range of vision by changing shape and position within the eye. While still evolving, accommodative IOLs aim to reduce dependency on glasses for both near and distant vision. As technological advancements continue, this segment holds promise for individuals seeking a more adaptive and natural visual experience post-cataract surgery.
Polymethylmethacrylate (PMMA)
Silicone
Hydrophobic Acrylic
Hydrophobic acrylic holds the largest share of the industry
A detailed breakup and analysis of the market based on the material have also been provided in the report. This includes polymethylmethacrylate (PMMA), silicone, and hydrophobic acrylic. According to the report, hydrophobic acrylic accounted for the largest market share.
Hydrophobic acrylic has emerged as the largest segment in the market due to its superior optical properties and biocompatibility. These lenses are known for their resistance to protein and water deposits, reducing the likelihood of postoperative complications. Hydrophobic acrylic IOLs provide excellent clarity and are suitable for various surgical techniques. Surgeons often prefer this material for its ease of handling and the reduced risk of posterior capsule opacification (PCO), contributing to the widespread adoption of hydrophobic acrylic lenses in modern cataract surgeries. The material's ability to maintain optical clarity over time and resist clouding has solidified its position as a leading choice.
PMMA has been a traditional material in intraocular lenses (IOLs) and, while its usage has decreased with technological advancements, it still holds a notable segment in the market. PMMA lenses are rigid and durable, providing stability within the eye. However, their lack of flexibility and potential for certain postoperative complications have led to a decline in their popularity compared to more modern materials like hydrophobic acrylic and silicone.
Silicone lenses offer flexibility and biocompatibility, contributing to their prevalence in the market. Known for their softness and ability to fold easily, silicone lenses facilitate less invasive surgical procedures. The material's inert nature reduces the risk of inflammation and allergic reactions. While not as widely used as hydrophobic acrylic, silicone remains a significant choice, particularly in cases where the surgeon prioritizes lens flexibility and patient comfort.
Hospitals
Ophthalmic Clinics
Ambulatory Care Centers
Eye Research Institutes
Hospitals represent the leading market segment
The report has provided a detailed breakup and analysis of the market based on the end use. This includes hospitals, ophthalmic clinics, ambulatory care centers, and eye research institutes. According to the report, hospitals represented the largest segment.
Hospitals constitute the largest segment of the market, serving as primary hubs for surgical procedures, including cataract surgeries requiring IOL implantation. The comprehensive infrastructure and diverse medical specialties within hospitals make them central to the diagnosis and treatment of ocular conditions. The high patient footfall in hospitals, coupled with the availability of advanced surgical facilities, positions them as key contributors to the demand for intraocular lenses. Moreover, hospitals often attract a wide range of patients, including those with complex ocular conditions, making them pivotal in the overall market share.
On the other hand, ophthalmic clinics represent a significant segment of the market, offering specialized care focused on eye health. These clinics, led by ophthalmologists and optometrists, are key contributors to the diagnosis and treatment of various eye disorders, including cataracts. Ophthalmic clinics provide a more specialized and focused environment for eye care, attracting patients seeking expert advice and surgical interventions. The efficiency and expertise of these clinics contribute to their substantial share in the IOL market, particularly for routine and elective eye surgeries.
Moreover, ambulatory care centers play a notable role in the market, offering a balance between the comprehensive services of hospitals and the specialized care of ophthalmic clinics. These centers provide outpatient surgical procedures, including cataract surgery with this lens implantation. The convenience of ambulatory care centers, offering timely and efficient procedures without the need for overnight hospital stays, appeals to patients and contributes to the demand for these lenses outside traditional hospital settings.
Furthermore, eye research institutes are crucial contributors to the market. These institutions focus on advancing knowledge in ophthalmology, developing new surgical techniques, and conducting clinical trials for innovative intraocular lens technologies. The insights and advancements generated by eye research institutes influence the broader market, shaping the future of these lens materials, designs, and surgical approaches. While not primary end-users for routine surgeries, these institutes play a pivotal role in driving innovation and elevating the standards of care in the field of ophthalmology.
North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
North America leads the market, accounting for the largest intraocular lens market share
The market research report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America accounted for the largest market share.
North America dominates the market, driven by advanced healthcare infrastructure, a high prevalence of cataracts, and a rapidly aging population. The region's well-established reimbursement policies and a strong focus on technological innovations contribute to the widespread adoption of premium IOLs. The presence of key market players, coupled with a proactive approach toward eye health and surgical interventions, solidifies North America's leading position in the global IOL market.
The Asia Pacific region is a significant and growing market for intraocular lenses, fueled by a large population, increasing awareness of eye health, and rising access to healthcare services. The prevalence of age-related eye conditions, including cataracts, in countries like China and India, propels the demand for IOLs. Furthermore, advancements in healthcare infrastructure and the growing disposable income in several Asia Pacific nations contribute to the expansion of the market in the region.
Europe stands as a prominent market for these lenses, driven by a well-established healthcare system, a high prevalence of age-related eye disorders, and a growing emphasis on minimally invasive surgical techniques. The region's aging population contributes significantly to the demand for cataract surgeries and, consequently, intraocular lenses. European countries also exhibit a strong inclination toward adopting innovative medical technologies, fostering the growth of the market in the region.
Latin America represents a burgeoning market for intraocular lenses, propelled by improving healthcare infrastructure and a rising awareness of eye health. The region's aging demographic contributes to an increased incidence of cataracts, driving the demand for lens implantation. While the market is still developing, Latin America showcases substantial growth potential, with increasing investments in healthcare and a growing focus on addressing visual impairments.
The Middle East and Africa exhibit a growing demand for these lenses, driven by improving healthcare accessibility and rising awareness of eye disorders. Although the market is in the early stages of development compared to other regions, an aging population and increasing investments in healthcare infrastructure contribute to the expansion of the market. As these regions continue to advance in medical technology adoption, the demand for intraocular lenses is expected to rise, albeit at a pace influenced by regional economic factors and healthcare development.
The key players in the market are actively engaged in strategic initiatives to maintain and expand their market presence. Continuous research and development efforts are directed towards the enhancement of intraocular lens technologies, focusing on improving optical outcomes, durability, and patient satisfaction. Companies are investing in the development of innovative materials and designs, such as advanced hydrophobic acrylics and multifocal lenses, to address evolving patient needs. Additionally, strategic collaborations, partnerships, and acquisitions are prevalent among key players, enabling them to strengthen their product portfolios and leverage complementary technologies. Market leaders are also actively involved in geographic expansion, targeting emerging markets with growing healthcare infrastructures.
Alcon Inc.
Bausch Health Companies Inc.
Carl Zeiss Meditec AG (Carl-Zeiss-Stiftung)
EyeKon Medical Inc.
Hoya Corporation
HumanOptics AG
Johnson & Johnson
Lenstec Inc.
Rayner Intraocular Lenses Limited
STAAR Surgical Company
(Please note that this is only a partial list of the key players, and the complete list is provided in the report.)
October 30, 2023: Alcon Inc. announced the full U.S. commercial availability of a cloud-based cataract planner, building on its leading image-guided clinic to OR connectivity.
December 21, 2023: Bausch Health Companies Inc. announced positive topline results from a global phase 2 study evaluating Amiselimod to treat ulcerative colitis.
December 15, 2023: Carl Zeiss Meditec AG announced its agreement to purchase the complete shareholding of D.O.R.C. Dutch Ophthalmic Research Center (International) B.V. from its current proprietor, Eurazeo SE in Paris, France.